FDA Greenlights Nasal Spray Flu Vaccine for Use at Home

The US Food and Drug Administration (FDA) recently approved the nasal spray influenza vaccine FluMist for at-home administration beginning in 2025, making it the first flu vaccine that won’t need to be administered by a clinician.

Authors

Publication Details

Journal
JAMA
Published
2024-10-18
DOI
https://doi.org/10.1001/jama.2024.21299
Citations
2
Primary Topic
Viral gastroenteritis research and epidemiology
Type
article
Field-Weighted Citation Impact
0.78
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

FDA Greenlights Nasal Spray Flu Vaccine for Use at Home

Samantha Anderer
2 citations
JAMA
Viral gastroenteritis research and epidemiology
0.78
article

FDA Greenlights Nasal Spray Flu Vaccine for Use at Home

Samantha Anderer
article en
2 citations

Abstract

The US Food and Drug Administration (FDA) recently approved the nasal spray influenza vaccine FluMist for at-home administration beginning in 2025, making it the first flu vaccine that won’t need to be administered by a clinician.

JAMAVol. 332(18)
Zero hunger
Openalex Percentile: Top 27%
Viral gastroenteritis research and epidemiology
0.78
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

FDA Greenlights Nasal Spray Flu Vaccine for Use at Home — Samantha Anderer · JAMA (2024) | TGRS Research Map | TGRS